2seventy bio, Inc. (TSVT)
NASDAQ: TSVT · Real-Time Price · USD
4.950
0.00 (0.00%)
Mar 28, 2025, 4:00 PM EDT - Market closed
2seventy bio Revenue
In the year 2024, 2seventy bio had annual revenue of $37.86M, down -62.28%. 2seventy bio had revenue of $2.93M in the quarter ending December 31, 2024, a decrease of -72.61%.
Revenue (ttm)
$37.86M
Revenue Growth
-62.28%
P/S Ratio
6.83
Revenue / Employee
$138,182
Employees
274
Market Cap
259.07M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
TSVT News
- 3 days ago - 2seventy bio Reports Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 14 days ago - 2SEVENTY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of 2seventy bio, Inc. - TSVT - Business Wire
- 17 days ago - ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of 2seventy bio, Inc. - PRNewsWire
- 17 days ago - Bristol Myers Squibb Scoops Up Its Blood Cancer Drug Partner 2seventy Bio In $286 Million Deal - Benzinga
- 17 days ago - Top 3 Health Care Stocks That May Keep You Up At Night In Q1 - Benzinga
- 17 days ago - Bristol Myers acquires cell therapy partner 2seventy bio for about $286 million - Reuters
- 18 days ago - 2seventy bio Enters into Definitive Agreement to be Acquired by Bristol Myers Squibb - Business Wire
- 4 weeks ago - 2seventy bio to Participate in the 2025 TD Cowen Healthcare Conference - Business Wire